BioCentury
ARTICLE | Company News

Mitsubishi Tanabe Pharma sales and marketing update

April 8, 2013 7:00 AM UTC

Mitsubishi's Mitsubishi Pharma Deutschland GmbH subsidiary launched BindRen colestilan in Germany and Austria to treat hyperphosphatemia in adult patients with stage 5 chronic kidney disease (CKD) re...